Recombinant multi-species Rad51D/RAD51D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Rad51D/RAD51D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a member of the RAD51 protein family. RAD51 family members are highly similar to bacterial RecA and Saccharomyces cerevisiae Rad51, which are known to be involved in the homologous recombination and repair of DNA. This protein forms a complex with several other members of the RAD51 family, including RAD51L1, RAD51L2, and XRCC2. The protein complex formed with this protein has been shown to catalyze homologous pairing between single- and double-stranded DNA, and is thought to play a role in the early stage of recombinational repair of DNA. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the downstream ring finger and FYVE-like domain containing 1 (RFFL) gene. [provided by RefSeq, Jan 2011]
The Alternative Names of target: BROVCA4,DNA repair protein RAD51 homolog 4,R51H3,RAD51 homolog D,RAD51-like protein 3,RAD51D,RAD51L3,Rad51D,Rad51d,Rad51l3,TRAD,Trad-d5

Target products collectionGo to Rad51D/RAD51D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10839-Ag-1/ GM-Tg-hg-IP10839-Ag-2 Human Rad51D/RAD51D protein Human
GM-Tg-rg-IP10839-Ag-1/ GM-Tg-rg-IP10839-Ag-2 Rat Rad51D/RAD51D protein Rat
GM-Tg-mg-IP10839-Ag-1/ GM-Tg-mg-IP10839-Ag-2 Mouse Rad51D/RAD51D protein Mouse
GM-Tg-cynog-IP10839-Ag-1/ GM-Tg-cynog-IP10839-Ag-2 Cynomolgus/Rhesus macaque Rad51D/RAD51D protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10839-Ag-1/ GM-Tg-felg-IP10839-Ag-2 Feline Rad51D/RAD51D protein Feline
GM-Tg-cang-IP10839-Ag-1/ GM-Tg-cang-IP10839-Ag-2 Canine Rad51D/RAD51D protein Canine
GM-Tg-bovg-IP10839-Ag-1/ GM-Tg-bovg-IP10839-Ag-2 Bovine Rad51D/RAD51D protein Bovine
GM-Tg-equg-IP10839-Ag-1/ GM-Tg-equg-IP10839-Ag-2 Equine Rad51D/RAD51D protein Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10839-Ag-1/ GM-Tg-hg-IP10839-Ag-2; GM-Tg-rg-IP10839-Ag-1/ GM-Tg-rg-IP10839-Ag-2;
GM-Tg-mg-IP10839-Ag-1/ GM-Tg-mg-IP10839-Ag-2; GM-Tg-cynog-IP10839-Ag-1/ GM-Tg-cynog-IP10839-Ag-2;
GM-Tg-felg-IP10839-Ag-1/ GM-Tg-felg-IP10839-Ag-2; GM-Tg-cang-IP10839-Ag-1/ GM-Tg-cang-IP10839-Ag-2;
GM-Tg-bovg-IP10839-Ag-1/ GM-Tg-bovg-IP10839-Ag-2; GM-Tg-equg-IP10839-Ag-1/ GM-Tg-equg-IP10839-Ag-2
Products Name Rad51D/RAD51D protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Rad51D/RAD51D
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Rad51D/RAD51D protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.